Smith Nathan T, Fernholz Ryan, Juresic Sanny
PharmD, Pharmacy, Mayo Clinic, Rochester, NY, USA.
PharmD, Pharmacy, Mayo Foundation for Medical Education and Research, Rochester, NY, USA.
J Pain Palliat Care Pharmacother. 2024 Dec;38(4):373-378. doi: 10.1080/15360288.2024.2400901. Epub 2024 Sep 9.
Opioid induced hyperalgesia in the postoperative setting presents a significant challenge for clinicians managing postoperative pain in opioid tolerant patients. Remifentanil is a fentanyl analog frequently utilized in anesthesia for its favorable pharmacokinetic profile. However, as described in the case report, it may also increase the risk of postoperative hyperalgesia. Management of postoperative pain in the setting of hyperalgesia should be approached in a stepwise fashion, emphasizing therapy options with analgesic effects achieved outside of the opioidergic system while maintaining a neutral opioid balance.
在术后环境中,阿片类药物诱导的痛觉过敏给管理阿片类药物耐受患者术后疼痛的临床医生带来了重大挑战。瑞芬太尼是一种芬太尼类似物,因其良好的药代动力学特性而常用于麻醉。然而,如病例报告中所述,它也可能增加术后痛觉过敏的风险。在痛觉过敏情况下,术后疼痛的管理应采用逐步推进的方式,强调在阿片类系统之外实现镇痛效果的治疗选择,同时保持阿片类药物平衡中立。